200 related articles for article (PubMed ID: 38253690)
61. Autoimmune encephalitis: suspicion in clinical practice and mimics.
Costa D; Sardoeira A; Carneiro P; Neves E; Santos E; da Silva AM; Samões R
J Neuroimmunol; 2022 Apr; 365():577824. PubMed ID: 35202952
[TBL] [Abstract][Full Text] [Related]
62. Mechanisms of autoimmune encephalitis.
Papi C; Milano C; Spatola M
Curr Opin Neurol; 2024 Jun; 37(3):305-315. PubMed ID: 38667756
[TBL] [Abstract][Full Text] [Related]
63. Autoantibody-associated movement disorders.
Mohammad SS; Ramanathan S; Brilot F; Dale RC
Neuropediatrics; 2013 Dec; 44(6):336-45. PubMed ID: 24203856
[TBL] [Abstract][Full Text] [Related]
64. N-methyl-D-aspartate receptor dysfunction by unmutated human antibodies against the NR1 subunit.
Wenke NK; Kreye J; Andrzejak E; van Casteren A; Leubner J; Murgueitio MS; Reincke SM; Secker C; Schmidl L; Geis C; Ackermann F; Nikolaus M; Garner CC; Wardemann H; Wolber G; Prüss H
Ann Neurol; 2019 May; 85(5):771-776. PubMed ID: 30843274
[TBL] [Abstract][Full Text] [Related]
65. A rare case of anti-LGI1 limbic encephalitis with concomitant positive NMDAR antibodies.
Ji T; Huang Z; Lian Y; Wang C; Zhang Q; Li J
BMC Neurol; 2020 Sep; 20(1):336. PubMed ID: 32894089
[TBL] [Abstract][Full Text] [Related]
66. Pathophysiological Effects of Autoantibodies in Autoimmune Encephalitides.
Ryding M; Mikkelsen AW; Nissen MS; Nilsson AC; Blaabjerg M
Cells; 2023 Dec; 13(1):. PubMed ID: 38201219
[TBL] [Abstract][Full Text] [Related]
67. Enhanced Dendritic Inhibition and Impaired NMDAR Activation in a Mouse Model of Down Syndrome.
Schulz JM; Knoflach F; Hernandez MC; Bischofberger J
J Neurosci; 2019 Jun; 39(26):5210-5221. PubMed ID: 31000585
[TBL] [Abstract][Full Text] [Related]
68. Autoimmune Encephalitis in Children.
Hardy D
Pediatr Neurol; 2022 Jul; 132():56-66. PubMed ID: 35640473
[TBL] [Abstract][Full Text] [Related]
69. Allosteric modulation of NMDA receptors prevents the antibody effects of patients with anti-NMDAR encephalitis.
Mannara F; Radosevic M; Planagumà J; Soto D; Aguilar E; García-Serra A; Maudes E; Pedreño M; Paul S; Doherty J; Quirk M; Dai J; Gasull X; Lewis M; Dalmau J
Brain; 2020 Sep; 143(9):2709-2720. PubMed ID: 32830245
[TBL] [Abstract][Full Text] [Related]
70. Glutamate receptor antibodies in neurological diseases: anti-AMPA-GluR3 antibodies, anti-NMDA-NR1 antibodies, anti-NMDA-NR2A/B antibodies, anti-mGluR1 antibodies or anti-mGluR5 antibodies are present in subpopulations of patients with either: epilepsy, encephalitis, cerebellar ataxia, systemic lupus erythematosus (SLE) and neuropsychiatric SLE, Sjogren's syndrome, schizophrenia, mania or stroke. These autoimmune anti-glutamate receptor antibodies can bind neurons in few brain regions, activate glutamate receptors, decrease glutamate receptor's expression, impair glutamate-induced signaling and function, activate blood brain barrier endothelial cells, kill neurons, damage the brain, induce behavioral/psychiatric/cognitive abnormalities and ataxia in animal models, and can be removed or silenced in some patients by immunotherapy.
Levite M
J Neural Transm (Vienna); 2014 Aug; 121(8):1029-75. PubMed ID: 25081016
[TBL] [Abstract][Full Text] [Related]
71. Posttransplant Anti-GABA
Togni CL; Frontzek K; Schubring-Giese M; Imbach LL; Jelcic I
Neurology; 2024 Apr; 102(7):e209245. PubMed ID: 38452326
[No Abstract] [Full Text] [Related]
72. Non-Hodgkin's Lymphoma of the Central Nervous System with N-Methyl-D-Aspartate Receptor Antibody Positivity - A Case Report.
Tunc H; Camkiran E; Gemici A; Irmak S; Ismayilzade H; Aliyev R; Bozkurt S; Midi I
Acta Neurol Taiwan; 2024 Jun; 33(2)():86-92. PubMed ID: 37848241
[TBL] [Abstract][Full Text] [Related]
73. Immune-mediated disorders.
Höftberger R; Lassmann H
Handb Clin Neurol; 2017; 145():285-299. PubMed ID: 28987176
[TBL] [Abstract][Full Text] [Related]
74. Glutamatergic autoencephalitides: an emerging field.
Panzer JA; Gleichman AJ; Lynch DR
J Neural Transm (Vienna); 2014 Aug; 121(8):957-68. PubMed ID: 24402576
[TBL] [Abstract][Full Text] [Related]
75. Anti-NMDAR encephalitis and other glutamate and GABA receptor antibody encephalopathies.
De Bruijn MA; Titulaer MJ
Handb Clin Neurol; 2016; 133():199-217. PubMed ID: 27112679
[TBL] [Abstract][Full Text] [Related]
76. Seizures and risk of epilepsy in anti-NMDAR, anti-LGI1, and anti-GABA
Shen CH; Fang GL; Yang F; Cai MT; Zheng Y; Fang W; Guo Y; Zhang YX; Ding MP
Ann Clin Transl Neurol; 2020 Aug; 7(8):1392-1399. PubMed ID: 32710704
[TBL] [Abstract][Full Text] [Related]
77. Cellular plasticity induced by anti-α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor encephalitis antibodies.
Peng X; Hughes EG; Moscato EH; Parsons TD; Dalmau J; Balice-Gordon RJ
Ann Neurol; 2015 Mar; 77(3):381-98. PubMed ID: 25369168
[TBL] [Abstract][Full Text] [Related]
78. Anti-NMDA receptor encephalitis presenting as fever with undetermined cause.
Liang CW; Chen TC
Int J Infect Dis; 2022 Sep; 122():365-367. PubMed ID: 35718296
[TBL] [Abstract][Full Text] [Related]
79. N-Methyl-d-aspartate Receptor Antibody Encephalitis: A Concise Review of the Disorder, Diagnosis, and Management.
Staley EM; Jamy R; Phan AQ; Figge DA; Pham HP
ACS Chem Neurosci; 2019 Jan; 10(1):132-142. PubMed ID: 30134661
[TBL] [Abstract][Full Text] [Related]
80. Input-Specific Synaptic Location and Function of the α5 GABA
Magnin E; Francavilla R; Amalyan S; Gervais E; David LS; Luo X; Topolnik L
J Neurosci; 2019 Jan; 39(5):788-801. PubMed ID: 30523065
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
